XSHE
002440
Market cap2.19bUSD
Oct 09, Last price
13.05CNY
1D
-0.15%
1Q
33.44%
IPO
75.88%
Name
Zhejiang Runtu Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1986 and headquartered in Shangyu, China, Zhejiang Runtu Co., Ltd. specializes in the production and distribution of dyes. The company boasts an extensive catalog of approximately 300 distinct chemical products, categorized across dyes, pigments, and additives. Its comprehensive range of dye products includes disperse, reactive, direct, blend, cationic, and vat varieties. Beyond its core dye offerings, Zhejiang Runtu also manufactures critical chemical intermediate products, textile auxiliaries, and industrial chemicals such as sulfuric acid, chlor-alkali, and hydrogen peroxide. While maintaining a strong presence within the Chinese market, the company extends its sales globally, exporting its goods to various international regions including Southeast Asia, the Middle East, Europe, and the United States.
Key people
Chengyu Zhou
Chief Financial Officer · since 2012
Jiewen Zhou
General Manager, Director · since 2023
Zhehu Jing
Deputy General Manager · since 2018
Boping Liu
Deputy General Manager, Secretary of the Board · since 2017
Heng Ru
Vice Chairman of the Board, Deputy General Manager · since 2023
Guangdong Ruan
Deputy General Manager, Director · since 2016
Jun Xu
Deputy General Manager · since 2022
Zhifeng Zhang
Deputy General Manager, Assistant General Manager · since 2023
Jingbo Ruan
Executive Chairman of the Board · since 2026
Xingcheng Ding
Director · since 2023
Jiachun Ruan
Director · since 2023
Dongfang Ma
Independent Director · since 2023
Independent Director · since 2023
Independent Director · since 2020
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||